Families Say Animal Studies Back Their Claims In Zofran MDL
Families who claim that GlaxoSmithKline's "off label" promotion of its anti-nausea drug Zofran for morning sickness led to birth defects urged the Massachusetts federal judge overseeing the multidistrict litigation on Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article